| ORIGINAL RESEARCH |
|
| Year : 2015 | Volume
: 6
| Issue : 2 | Page : 60-64 |
|
|
Salivary IgA concentration in diabetic patients compared to healthy controls
Farimah Sardari1, Afshin Tahmasbi2, Arash Ghanbarzadegan3
1 Department of Oral Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
2 Department of Internal Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
3 Department of Dental Student, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
Correspondence Address:
Asst Prof. Farimah Sardari
Department of Oral Medicine, Rafsanjan University of Medical Sciences, Rafsanjan
Iran
 Source of Support: This study was financially supported by funds of Rafsanjan University of Medical Sciences, Rafsanjan, Iran (Grant number: 390049).,, Conflict of Interest: None  | Check |
DOI: 10.4103/2155-8213.158478
|
|
|
Introduction: The alterations in salivary flow rate and its compositions could affect the development, symptoms, and severity of oral changes in diabetic patients. The aim of this study was to assess the concentration of salivary IgA in type I in comparison with type II diabetic patients and healthy controls. Materials and Methods: In this cross-sectional study, 25 patients with type I diabetes, 25 patients with type II diabetes, and 25 control subjects (12 subjects for the type I and 13 subjects for the type II) were enrolled. Unstimulated saliva samples were collected by spitting method and the concentration of salivary IgA was measured byenzyme-linked immunosorbent assay (ELISA) method. Results: The mean of salivary IgA in type I diabetic patients was 148.3 ± 38.7 μg/ml and in their controls was 65.8 ± 17.4 μg/ml (P < 0.001). In type II diabetic patients the mean of salivary IgA was 67.3 ± 20.6 μg/ml and in their controls was 63.3 ± 15.2 μg/ml. There was no significant difference between patients with type II diabetes and controls (P = 0.54). The mean of salivary IgA in patients with type I diabetes was significantly higher than in patients with type II diabetes (148.3 ± 38.7 versus 67.3 ± 20.6 μg/ml, respectively, P < 0.001). Conclusions: Level of salivary IgA in type II diabetic patients in comparison with their healthy control did not show any significant difference, but in type I diabetic patients was higher than that of healthy controls and type II diabetic patients. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
